EMEA Surgical Microscopes Market Size, Share, & Trends Analysis Report By Type (On Casters, Wall Mounted), By Application (Ophthalmology, ENT Surgery), End Use (Hospital, Physician Clinics), And Segment Forecasts, 2025 - 2030

EMEA Surgical Microscopes Market Size, Share, & Trends Analysis Report By Type (On Casters, Wall Mounted), By Application (Ophthalmology, ENT Surgery), End Use (Hospital, Physician Clinics), And Segment Forecasts, 2025 - 2030


DNA Diagnostics Market Growth & Trends

The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights
  • The PCR-based diagnostics segment held the largest share of 49.40% in 2024, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics
  • NGS DNA diagnosis is projected to grow fastest CAGR of 13.9% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.
  • Cancer genetics tests segment held the largest share of 29.80% in 2024. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.
  • North America DNA diagnostics market dominated the overall global market and accounted for the 42.72% revenue share in 2024.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Estimates and Forecast Timeline
1.2. Research Methodology
1.2.1. Information Procurement
1.2.2. Purchased Database
1.2.3. GVR’s Internal Database
1.2.4. Secondary Sources
1.2.5. Primary Research
1.3. Information or Data Analysis
1.3.1. Data Analysis Models
1.4. Market Formulation & Data Visualization
1.5. Model Details
1.5.1. Commodity Flow Analysis
1.6. Objectives
1.6.1. Objective - 1
1.6.2. Objective - 2
1.6.3. Objective - 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Type
2.2.2. Application
2.2.3. End Use
2.2.4. Regional Outlook
2.3. Competitive Outlook
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Product Innovations
3.2.1.2. Increasing Demand for Minimally Invasive Surgeries
3.2.1.3. Increasing Geriatric Population
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Surgical Microscopes
3.2.2.2. Shortage of Skilled Workers
3.3. Business Environment Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. EMEA Surgical Microscopes Market: Type Estimates & Trend Analysis
4.1. EMEA Surgical Microscopes Market: Type Movement Analysis
4.2. EMEA Surgical Microscopes Market: Type Segment Dashboard
4.3. Type Movement & Market Share Analysis, 2024 & 2030
4.4. EMEA Surgical Microscopes Market Estimates & Forecast by Type
4.5. On Casters
4.5.1. On casters market, 2018 - 2030 (USD Million)
4.6. Wall mounted
4.6.1. Wall mounted market, 2018 - 2030 (USD Million)
4.7. TableTop
4.7.1. Tabletop market, 2018 - 2030 (USD Million)
4.8. Ceiling Mounted
4.8.1. Ceiling mounted market, 2018 - 2030 (USD Million)
Chapter 5. EMEA Surgical Microscopes Market: Application Estimates & Trend Analysis
5.1. EMEA Surgical Microscopes Market: Application Movement Analysis
5.2. EMEA Surgical Microscopes Market: Application Segment Dashboard
5.3. Application Movement & Market Share Analysis, 2024 & 2030
5.4. EMEA Surgical Microscopes Market Estimates & Forecast by Application
5.5. Neurosurgery and Spine Surgery
5.5.1. Neurosurgery and Spine Surgery market, 2018 - 2030 (USD Million)
5.6. ENT Surgery
5.6.1. ENT surgery market, 2018 - 2030 (USD Million)
5.7. Dentistry
5.7.1. Dentistry market, 2018 - 2030 (USD Million)
5.8. Gynecology
5.8.1. Gynecology market, 2018 - 2030 (USD Million)
5.9. Urology
5.9.1. Urology market, 2018 - 2030 (USD Million)
5.10. Ophthalmology
5.10.1. Ophthalmology market, 2018 - 2030 (USD Million)
5.11. Plastic & Reconstructive Surgeries
5.11.1. Plastic & Reconstructive Surgeries market, 2018 - 2030 (USD Million)
5.12. Other Surgeries
5.12.1. Other Surgeries market, 2018 - 2030 (USD Million)
Chapter 6. EMEA Surgical Microscopes Market: End Use Estimates & Trend Analysis
6.1. EMEA Surgical Microscopes Market: End Use Movement Analysis
6.2. EMEA Surgical Microscopes Market: End Use Segment Dashboard
6.3. End Use Movement & Market Share Analysis, 2024 & 2030
6.4. EMEA Surgical Microscopes Market Estimates & Forecast by End Use
6.5. Hospital
6.5.1. Hospital market, 2018 - 2030 (USD Million)
6.6. Physician Clinics and Other Settings
6.6.1. Physician clinics and other settings market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis
7.3. Company Share Analysis
7.4. Strategy Mapping
7.4.1. Partnership/Collaboration/Alliance
7.4.2. New Service Launch
7.4.3. Mergers & Acquisitions
7.4.4. Others
7.5. Company Profiles/Listing
7.5.1. Zeiss
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Olympus Corp.
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Leica Microsystems
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Alcon, Inc.
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Takagi Seiko Co., Ltd.
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Topcon Corp.
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Haag-Streit Surgical Gmbh
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. ARI Medical Technology Co., Ltd.
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Synaptive Medical
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Chammed Co., Ltd.
7.5.10.1. Overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. Atmos Medizintechnik GmbH & Company KG
7.5.11.1. Overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Intamed
7.5.12.1. Overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Al Amin Medical Instruments Co. Ltd.
7.5.13.1. Overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Banco Bilbao Vizcaya Argentaria S.A.
7.5.14.1. Overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings